Dr. Albert Bourla | Pfizer
The CEO of Pfizer on Developing a Vaccine in Record Time
Ugur Sahin
Why the Pfizer CEO selling 62% of his stock the same day as the vaccine announcement looks bad | Financial Post
Pfizer expects $15B in COVID-19 vaccine sales in 2021; some analysts see more | S&P Global Market Intelligence
Chief executives of mRNA vaccine groups earned $100mn in pandemic pay | Financial Times
Coronavirus vaccine: Pfizer CEO says he'd take it first to ease doubt
Pfizer CEO Joins Host of Executives at Covid-19 Vaccine Makers in Big Stock Sale - WSJ
Meet Married BioNTech Billionaires Who Helped Create Pfizer Vaccine
Pfizer hands CEO massive pay raise—plus $8M bonus—to dissuade him from retiring | Fierce Pharma
Pfizer CEO Albert Bourla sold stock the day he announced promising vaccine news | CNN Business
Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021
Wir sind Pfizer Deutschland
Albert Bourla: Net Worth, Biography, Age, Career, Salary & More - MTM
Ex-Pfizer CEO Ian Read sees 2018 pay slashed by a third as incentive package plummets | Fierce Pharma
Shantanu Narayen - Wikipedia
Albert Bourla - STAT
Pfizer CEO Albert Bourla sold stock the day he announced promising vaccine news | CNN Business
Vaccine Capitalism: a run-down of the huge profits being made from COVID-19 vaccines - Corporate Watch
Coronavirus vaccine: Pfizer CEO sold $5.6 million of stock as company announced positive data
Pfizer expects $15B in COVID-19 vaccine sales in 2021; some analysts see more | S&P Global Market Intelligence
Pfizer (PFE) CEO Albert Bourla, Pharma Executives Sell Stock in Covid Rally - Bloomberg
Pfizer CEO on Omicron Variant and Vaccine Efficacy
Three Billionaires Behind Pfizer's Vaccine Partner BioNTech Are $2 Billion Richer After It Announces Covid-19 Vaccine Results
Albert Bourla - Wikipedia
The CEO of Pfizer on Developing a Vaccine in Record Time
Pfizer CEO: What's next for vaccines, tech and the pandemic | World Economic Forum
10 US marijuana CEOs get million-dollar pay in 2020 as disclosure practices questioned
